Literature DB >> 23539416

Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1.

Mehdi Moghanibashi1, Ferdous Rastgar Jazii, Zahra-Soheila Soheili, Maryam Zare, Aliasghar Karkhane, Kazem Parivar, Parisa Mohamadynejad.   

Abstract

Nuclear pore complex (NPC) is the only corridor for macromolecules exchange between nucleus and cytoplasm. NPC and its components, nucleoporins, play important role in the diverse physiological processes including macromolecule exchange, chromosome segregation, apoptosis and gene expression. Recent reports also suggest involvement of nucleoporins in carcinogenesis. Applying proteomics, we analyzed expression pattern of the NPC components in a newly established esophageal cancer cell line from Persia (Iran), the high-risk region for esophageal cancer. Our results indicate overexpression of Hsc70 and downregulation of subunit alpha type-3 of proteasome, calpain small subunit 1, and eIF5A-1. Among these proteins, Hsc70 and eIF5A-1 are in direct interaction with NPC and involved in the nucleocytoplasmic exchange. Hsc70 plays a critical role as a chaperone in the formation of a cargo-receptor complex in nucleocytoplasmic transport. On the other hand, it is an NPC-associated protein that binds to nucleoporins and contributes in recycling of the nucleocytoplasmic transport receptors in mammals and affects transport of proteins between nucleus and cytoplasm. The other nuclear pore interacting protein: eIF5A-1 binds to the several nucleoporins and participates in nucleocytoplasmic transport. Altered expression of Hsc70 and eIF5A-1 may cause defects in nucleocytoplasmic transport and play a role in esophageal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539416     DOI: 10.1007/s10142-013-0320-9

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  55 in total

1.  Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity.

Authors:  F Gharahdaghi; C R Weinberg; D A Meagher; B S Imai; S M Mische
Journal:  Electrophoresis       Date:  1999-03       Impact factor: 3.535

Review 2.  Transport of messenger RNA from the nucleus to the cytoplasm.

Authors:  Charles N Cole; John J Scarcelli
Journal:  Curr Opin Cell Biol       Date:  2006-05-08       Impact factor: 8.382

3.  Nucleoporins prevent DNA damage accumulation by modulating Ulp1-dependent sumoylation processes.

Authors:  Benoit Palancade; Xianpeng Liu; Maria Garcia-Rubio; Andrès Aguilera; Xiaolan Zhao; Valérie Doye
Journal:  Mol Biol Cell       Date:  2007-05-30       Impact factor: 4.138

Review 4.  Comparative proteomic analyses of the nuclear envelope and pore complex suggests a wide range of heretofore unexpected functions.

Authors:  Dzmitry G Batrakou; Alastair R W Kerr; Eric C Schirmer
Journal:  J Proteomics       Date:  2008-09-27       Impact factor: 4.044

5.  Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes.

Authors:  Maya Capelson; Yun Liang; Roberta Schulte; William Mair; Ulrich Wagner; Martin W Hetzer
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

Review 6.  eIF5A isoforms and cancer: two brothers for two functions?

Authors:  M Caraglia; M H Park; E C Wolff; M Marra; A Abbruzzese
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

Review 7.  The role of nuclear envelope calcium in modifying nuclear pore complex structure.

Authors:  Elizabeth S Erickson; Olivia L Mooren; David Moore; Jeffrey R Krogmeier; Robert C Dunn
Journal:  Can J Physiol Pharmacol       Date:  2006 Mar-Apr       Impact factor: 2.273

8.  Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells.

Authors:  Paul M J Clement; Hans E Johansson; Edith C Wolff; Myung H Park
Journal:  FEBS J       Date:  2006-03       Impact factor: 5.542

9.  The 70-kD heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors.

Authors:  Shingo Kose; Maiko Furuta; Makiko Koike; Yoshihiro Yoneda; Naoko Imamoto
Journal:  J Cell Biol       Date:  2005-10-03       Impact factor: 10.539

10.  Proteomic analysis of the mammalian nuclear pore complex.

Authors:  Janet M Cronshaw; Andrew N Krutchinsky; Wenzhu Zhang; Brian T Chait; Michael J Matunis
Journal:  J Cell Biol       Date:  2002-08-26       Impact factor: 10.539

View more
  6 in total

Review 1.  Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.

Authors:  Björn L D M Brücher; Yan Li; Philipp Schnabel; Martin Daumer; Timothy J Wallace; Rainer Kube; Bruno Zilberstein; Scott Steele; Jan L A Voskuil; Ijaz S Jamall
Journal:  Clin Transl Med       Date:  2016-04-06

Review 2.  Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.

Authors:  Suman Chatterjee; Timothy F Burns
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

Review 3.  Localization and Functional Roles of Components of the Translation Apparatus in the Eukaryotic Cell Nucleus.

Authors:  Zaur M Kachaev; Sergey D Ivashchenko; Eugene N Kozlov; Lyubov A Lebedeva; Yulii V Shidlovskii
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

Review 4.  Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets.

Authors:  Rajani Rai; Amy L Kennedy; Zitha Redempta Isingizwe; Pouya Javadian; Doris Mangiaracina Benbrook
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

5.  Development of a prognostic nomogram based on an eight-gene signature for esophageal squamous cell carcinoma by weighted gene co-expression network analysis (WGCNA).

Authors:  Jiahong Xie; Pingshan Yang; Hongjian Wei; Peiwen Mai; Xiaoli Yu
Journal:  Ann Transl Med       Date:  2022-01

6.  Targeted Imaging Agent to HSP70 Induced In Vivo.

Authors:  Pradip Ghosh; Brian E O'Neill; King C Li
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.